Solid Biosciences Inc. Financial Ratios — SLDB Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-114.24	-83.24	-42.43	-40.96	-56.79	-94.57	-109.9
Return on Assets (%)	- -	-44.72	-89.22	-69.32	-96.45	-64.3	-35.78	-34.91	-45.16	-70.53	-82.78
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	100	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-508.74	-1,196.76	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-530.5	-1,226.51	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	62.28	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-530.01	-1,062.28	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-530.01	-1,062.28	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-530.01	-1,062.28	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.97	-19.86	-37.27	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-114.24	-83.24	-42.43	-40.96	-56.79	-94.57	-109.9

Credit (USD)

Credit Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	1	7	5	2	29	26	24	21
ST Debt	- -	- -	- -	- -	2	2	1	3	2	3	2
LT Debt	- -	- -	- -	1	5	3	1	26	24	21	19
Total Debt/EBITDA	- -	- -	- -	-0.01	-0.06	-0.06	-0.03	-0.29	-0.26	-0.19	-0.12
Net Debt/EBITDA	4.36	0.3	0.96	1.17	0.65	1.87	1.72	1.6	0.73	0.63	0.34
Total Debt/EBIT	- -	- -	- -	-0.01	-0.06	-0.06	-0.03	-0.29	-0.25	-0.19	-0.12
Net Debt/EBIT	4.36	0.3	0.95	1.14	0.64	1.79	1.65	1.57	0.71	0.62	0.33
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-231.21	-374.33	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-234.66	-376.26	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-237.08	-381.55	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-121.22	-207.6	-77.77	89.67	77.36	77.17	89.6	81.33	76.68	72.75	77.41
Long-Term Debt/Equity (%)	- -	- -	- -	0.69	6.43	2.23	0.27	12.27	18.93	15.42	10.59
Long-Term Debt/Capital (%)	- -	- -	- -	0.68	5.91	2.15	0.27	10.82	15.67	13.11	9.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.62	4.97	1.72	0.24	9.98	14.52	11.22	8.2
Total Debt/Equity (%)	- -	- -	- -	0.82	8.83	3.9	0.99	13.49	20.77	17.62	11.76
Total Debt/Capital (%)	- -	- -	- -	0.82	8.11	3.75	0.98	11.88	17.2	14.98	10.52
Total Debt/Total Assets (%)	- -	- -	- -	0.74	6.83	3.01	0.89	10.97	15.92	12.81	9.1
Net Debt to Equity	143.51	20.27	87.89	-68.99	-95	-117.15	-57.22	-73.41	-58.52	-58.46	-33.28
Net Debt/Capital (%)	58.93	16.85	46.78	-216.73	-686.68	883.9	-130.72	-183.17	-94.01	-98.83	-42.4
EBITDA	-7	-26	-54	-74	-116	-83	-69	-97	-102	-127	-178
EBITDA-CapEx	-7	-26	-57	-82	-121	-83	-71	-100	-103	-128	-179
Operating Income (Loss)	-7	-26	-55	-76	-119	-86	-72	-99	-104	-130	-179

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.98	5.48	6.13	9.81	4.57	6.32	8.8	9.5	8.52	4.92	5.61
Current Ratio	4	5.82	6.27	10.31	4.72	6.49	9.43	9.76	8.94	5.2	6.14
Quick Ratio	3.98	5.48	6.13	9.81	4.57	6.32	8.81	9.5	8.52	4.92	5.61
CFO/Avg Current Liab	- -	-1.93	-4.76	-5.91	-6.03	-2.65	-3.23	-4.25	-5.09	-4.47	-4.9
Common Equity/Total Assets	-121.22	-207.6	-77.77	89.67	77.36	77.17	89.6	81.33	76.68	72.75	77.41
Long-Term Debt/Equity (%)	- -	- -	- -	0.69	6.43	2.23	0.27	12.27	18.93	15.42	10.59
Long-Term Debt/Capital (%)	- -	- -	- -	0.68	5.91	2.15	0.27	10.82	15.67	13.11	9.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.62	4.97	1.72	0.24	9.98	14.52	11.22	8.2
Total Debt/Equity (%)	- -	- -	- -	0.82	8.83	3.9	0.99	13.49	20.77	17.62	11.76
Total Debt/Capital (%)	- -	- -	- -	0.82	8.11	3.75	0.98	11.88	17.2	14.98	10.52
Total Debt/Total Assets (%)	- -	- -	- -	0.74	6.83	3.01	0.89	10.97	15.92	12.81	9.1
CFO/Total Liabilities	-5.56	-25.62	-31.91	-487.01	-395.82	-144.82	-321.75	-201.66	-244.89	-194.52	-297.52
CFO/CapEx	- -	-51.33	-18.99	-9.03	-21.13	-62.96	-60.71	-32.5	-62.17	-152.92	-135.55
Altman's Z-Score	-1.19	-4.03	-3.72	36.74	-2.05	5.85	1.98	-2.05	-4.89	-5.39	-2.33

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	247.64	147.16	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	1.47	2.48	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	950	205	643	193	105	125	162	445
- Cash & Cash Equivalents	29	8	52	86	76	155	119	155	74	80	60
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	48	46	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	1	7	5	2	29	26	24	21
Enterprise Value	-8	9	-69	828	128	494	-13	-80	28	37	279
Total Capital	-20	-38	-59	126	87	137	210	240	153	161	201
Total Debt/Capital (%)	- -	- -	- -	0.82	8.11	3.75	0.98	11.88	17.2	14.98	10.52
Total Debt / EV	- -	- -	- -	- -	0.06	0.01	-0.16	-0.36	0.94	0.65	0.08
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	891	179	394	187	46	122	163	494
Diluted Enterprise Value	19	39	-52	806	110	244	70	-81	74	107	455
EV per Share	- -	4.1	- -	350.59	41.81	87.27	- -	- -	1.36	0.92	3.53
TTM Sales	- -	- -	- -	- -	- -	- -	14	8	- -	- -	- -
TTM EBITDA	-7	-26	-54	-74	-116	-83	-69	-97	-102	-127	-178
TTM Operating Income	-7	-26	-55	-76	-119	-86	-72	-99	-104	-130	-179
TTM Cash Flow to Firm	-4	-20	-43	-70	-93	-57	-78	-98	-94	-100	-156
TTM Free Cash Flow to Firm	-4	-20	-41	-62	-88	-56	-76	-95	-92	-99	-155

Multiples (USD)

Valuation Multiples API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-14.28	-2.03	-7.07	-2.44	-0.48	-1.32	-1.64	-3.18
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-8	9	-69	828	128	494	-13	-80	28	37	279
Low Price	- -	- -	- -	102.45	41.25	28.95	23.85	5.21	1.81	3.85	2.41
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-13.14	-3.31	-1.89	-6.1	-1.1	-0.97	-2.61	-2.4
Price/Earnings High	- -	- -	- -	-24.39	-11.29	-4.85	-17.13	-2.73	-1.7	-4.93	-3.7
Price/Earnings Low	- -	- -	- -	-3.04	-0.95	-1.14	-2.35	-0.52	-0.37	-1.26	-1.21
Price/Book Value	- -	- -	- -	7.59	2.56	4.87	0.93	0.5	0.99	1.18	2.47
Price/Book Value Average	- -	- -	- -	8.37	5.54	2.06	2.18	1.03	0.75	2.35	2.1
Price/Book Value High	- -	- -	- -	15.52	18.87	5.3	6.14	2.54	1.32	4.44	3.23
Price/Book Value Low	- -	- -	- -	1.93	1.58	1.24	0.84	0.48	0.29	1.14	1.06
Price/Tangible Book Value	- -	- -	- -	7.59	2.56	4.87	0.93	0.5	0.99	1.18	2.47
Price/Tangible Book Value Average	- -	- -	- -	8.37	5.54	2.06	2.18	1.03	0.75	2.35	2.1
Price/Tangible Book Value High	- -	- -	- -	15.52	18.87	5.3	6.14	2.54	1.32	4.44	3.23
Price/Tangible Book Value Low	- -	- -	- -	1.93	1.58	1.24	0.84	0.48	0.29	1.14	1.06
Price/Sales	- -	- -	- -	- -	- -	- -	13.72	5.66	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	32.32	11.72	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	90.78	28.95	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	12.46	5.48	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-12.7	-1.93	-6.96	-2.4	-0.47	-1.3	-1.63	-3.16
Price/Cash Flow Average	- -	- -	- -	-14.01	-4.19	-2.95	-5.66	-0.97	-0.99	-3.25	-2.68
Price/Cash Flow High	- -	- -	- -	-25.99	-14.28	-7.56	-15.9	-2.39	-1.73	-6.14	-4.13
Price/Cash Flow Low	- -	- -	- -	-3.24	-1.2	-1.77	-2.18	-0.45	-0.38	-1.57	-1.35
Price/Free Cash Flow Average	- -	- -	- -	-15.75	-4.4	-2.99	-5.76	-1	-1	-3.27	-2.7
Price/Free Cash Flow High	- -	- -	- -	-29.22	-14.98	-7.68	-16.17	-2.47	-1.76	-6.18	-4.16
Price/Free Cash Flow Low	- -	- -	- -	-3.64	-1.25	-1.8	-2.22	-0.47	-0.39	-1.58	-1.36
EV/Sales Average	- -	- -	- -	- -	- -	- -	24.81	11.25	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	85.22	50.85	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	4.29	- -	- -	- -	- -
EV/EBITDA Average	-2.89	-1.52	0.96	-12.98	-3.22	-1.49	-4.88	-0.94	-0.47	-2.09	-1.91
EV/EBITDA High	-2.89	-1.52	0.96	-25.06	-12.38	-6.66	-16.75	-4.25	-1.17	-4.34	-3.06
EV/EBITDA Low	-2.89	-1.52	0.96	-2.11	-0.49	-0.17	-0.84	0.26	0.11	-0.78	-0.85
EV/EBIT Average	-2.89	-1.52	0.95	-12.71	-3.14	-1.42	-4.68	-0.92	-0.45	-2.05	-1.89
EV/EBIT High	-2.89	-1.52	0.95	-24.55	-12.08	-6.36	-16.06	-4.15	-1.14	-4.26	-3.03
EV/EBIT Low	-2.89	-1.52	0.95	-2.07	-0.48	-0.16	-0.81	0.25	0.1	-0.77	-0.85
Last Price	- -	- -	- -	402	66.75	113.7	26.25	5.38	6.14	4	5.64
High Price	- -	- -	- -	822.6	492.75	123.6	173.7	27.53	8.2	15.05	7.37
Enterprise Value Average	19	39	-52	962	375	123	338	91	47	266	339
Enterprise Value High	19	39	-52	1,858	1,442	550	1,161	412	119	553	543
Enterprise Value Low	19	39	-52	157	57	14	58	-25	-11	100	152

Shares Outstanding	2	2	2	2	3	6	7	20	20	40	79
Diluted Weighted Avg Shares	1	1	2	2	3	3	7	9	20	41	88
Basic Weighted Avg Shares	1	1	2	2	3	3	7	9	20	41	88
Revenue per Share	- -	- -	- -	- -	- -	- -	1.91	0.95	- -	- -	- -
EBITDA per Share	-5.12	-19.9	-25.32	-33.43	-43.37	-23.84	-9.73	-11.38	-5.12	-3.12	-2.03
Operating Income per Share	-5.12	-19.95	-25.53	-34.13	-44.42	-24.97	-10.15	-11.66	-5.25	-3.18	-2.05
Basic EPS, GAAP	-5.03	-13.44	-17.4	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Basic EPS from Cont Ops	-5.2	-18.54	-24.75	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Diluted EPS, GAAP	-5.03	-13.44	-17.4	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Diluted EPS from Cont Ops	-5.2	-18.54	-24.75	-33.73	-43.64	-25.5	-10.14	-10.1	-4.83	-3.06	-1.99
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.28	-15.69	-20.12	-31.66	-34.52	-16.35	-10.92	-11.51	-4.74	-2.45	-1.79
Free Cash Flow per Basic Share	-3.28	-16	-21.18	-35.16	-36.15	-16.61	-11.1	-11.86	-4.81	-2.47	-1.8
Cash & Equivalents per Share	25.78	17.53	32.16	51.84	27.24	27.34	28.25	10.93	6.06	3.68	2.38
Book Value per Share	-31.42	-39.26	-27.58	53	26.11	23.34	28.3	10.82	6.2	3.39	2.28
Tangible Book Value per Share	-31.42	-39.26	-27.58	53	26.11	23.34	28.3	10.82	6.2	3.39	2.28

Solid Biosciences Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)